Clinical Trial Update: Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study) [Phase 3]

View source ↗

Summary

Phase 3 STROKER trial assessing systemic therapy alone versus systemic therapy plus stereotactic body radiotherapy for oligometastatic renal cell carcinoma; cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Renal Cell Carcinoma (Kidney Cancer), Kidney Cancer Metastatic | Phase 3 | Status: RECRUITING